Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tylosin

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 42Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CVMP initiates review of withdrawal periods of certain tylosin injectable products used in pigs
    CVMP initiates review of withdrawal periods of certain tylosin injectable products used in pigs

    25 Jan 2019

    // EMA

    https://www.ema.europa.eu/en/news/committee-medicinal-products-veterinary-use-cvmp-meeting-22-24-january-2019

    EMA
    25 Jan 2019
    Share Share
    Backed by giants, antibiotics upstart Macrolide $20M &an ex-Novartis exec as CEO
    Backed by giants, antibiotics upstart Macrolide $20M &an ex-Novartis exec as CEO

    03 Apr 2018

    // B. Meiling ENDPTS

    https://endpts.com/backed-by-giants-antibiotics-upstart-macrolide-gets-20m-and-an-ex-novartis-exec-as-ceo/

    B. Meiling ENDPTS
    03 Apr 2018
    Share Share
    Longtime Novartis exec takes the helm at Macrolide Pharma
    Longtime Novartis exec takes the helm at Macrolide Pharma

    03 Apr 2018

    // Amirah Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/longtime-novartis-exec-takes-helm-at-macrolide-pharma

    Amirah Al Idrus FIERCE BIOTECH
    03 Apr 2018
    Share Share
    Backed by giants, antibiotics upstart Macrolide gets $20M, ex-Novartis exec CEO
    Backed by giants, antibiotics upstart Macrolide gets $20M, ex-Novartis exec CEO

    03 Apr 2018

    // B. Meiling ENDPTS

    https://endpts.com/backed-by-giants-antibiotics-upstart-macrolide-gets-20m-and-an-ex-novartis-exec-as-ceo/

    B. Meiling ENDPTS
    03 Apr 2018
    Share Share
    Macrolide Pharmaceuticals Scientific Founder publishes new findings on groundbreaking technology for novel macrolide antibiotics
    Macrolide Pharmaceuticals Scientific Founder publishes new findings on groundbreaking technology for novel macrolide antibiotics

    25 May 2016

    // CPHI ONLINE

    http://cphi-online.com/macrolide-pharmaceuticals-scientific-founder-news040861.html

    CPHI ONLINE
    25 May 2016
    Share Share